intoxicant.wiki2catechol4school
Layout
Plant or preparation · Cannabinoid

Cannabis

Also called Marijuana, Weed, Pot, Mary Jane, Grass, Herb, Green, Bud, Tree, THC

Why a "revision used" link? Anyone can edit Wikipedia at any time, so the article you open today may not say what it said when we read it. This link opens the exact version we read on 24 October 2026, frozen as it was. It is the only way to check that every quote on this page matches its source word for word. Newer versions may correct or change things. When we re-check this page against a newer version, the edit log records it. How we cite

Common dose · Oral5–10 mg THC PW
Onset20–60 minutes PW
Total4–10 hours PW
After-effects6–12 hours PW

Dosage

When sources disagree, both rows are shown as published. Nothing is averaged or merged.

Oral

SourceThresholdLightCommonStrongHeavy
PsychonautWiki1 mg THC PW2.5–5 mg THC PW5–10 mg THC PW10–25 mg THC PW25 mg THC+ PW

Smoked

SourceThresholdLightCommonStrongHeavy
PsychonautWiki0.4 mg THC PW0.4–2 mg THC PW2–4 mg THC PW4–10 mg THC PW10 mg THC+ PW

TripSit dose text

TripSit's factsheet also states its doses as text. Its smoked table rows are left out above because this text gives different numbers for that route.

Smoked Light: 33mg Common: 66mg Strong: 100mg. Oral Light: 10-20mg Common: 20-60mg Strong: 60-100mg+ TS

What dose are you on? (self-reported, unverified)
Read this first. These numbers come from anonymous visitors typing in a box. Nobody checks them. People misjudge, mistype, troll, or take untested products of unknown strength. They are not a dose guide and never override the sourced table above. They exist only so the sourced ranges can be compared with what people say they take. If you are deciding what to take, use the sourced table, start low, and read the risks section.
Running self-reports

No reports yet.

Reports are anonymous, one per browser per day per route. Counts under 20 are shown but marked as too few to mean anything. Until accounts launch, reports stay in this browser only.

Duration

Route · sourceOnsetCome-upPeakOffsetTotalAfter-effects
Oral · PsychonautWiki20–60 minutes PW30–60 minutes PW1–2 hours PW4–6 hours PW4–10 hours PW6–12 hours PW
Smoked · PsychonautWiki0.1–10 minutes PW5–10 minutes PW15–45 minutes PW3–4 hours PW2.5–5 hours PW45–180 minutes PW
Sublingual · PsychonautWiki1–10 minutes PW15–30 minutes PW30–60 minutes PW4–6 hours PW3–7 hours PW–

TripSit factsheet

Onset
Oral: 30-120 minutes · Smoked: 1-10 minutes TS
Duration
Oral: 4-10 hours · Smoked: 1-4 hours TS
Aftereffects
Oral: 6-24 hours · Smoked: 2-24 hours TS

Mixing

Acute combinations: what happens when these are taken close together. Entries backed by a medical journal or agency are listed first.

Backed by medical journals

Awaiting sourcePeer-reviewed reports on acute combinations, from PubMed and the journals the harm reduction sites cite.

PsychonautWiki also lists dangerous combinations shared across a whole group (cannabis) in a table this page does not copy. Read that list on PsychonautWiki.

TripSit combination chart

TripSit rates each pairing. Only pairings with a number carry a citation from TripSit. See the whole chart, with TripSit's note for every pairing.

Caution

2c-t-x TS2c-x TS5-meo-xxt TSamphetamines TSamt TScocaine TSdmt TSdox TSlsd TSmescaline TSmushrooms TSnbomes TS

Low Risk & Synergy

Low Risk & No Synergy

caffeine TSssris TS

Low Risk & Decrease

Risks and toxicity

Despite its reputation for being a benign substance, it is important to be aware that cannabis use is associated with distinct risks. Acute adverse effects include anxiety, hyperemesis syndrome, impaired coordination and judgment, suicidal ideations/tendencies, and psychotic symptoms. PW

It is strongly advised to use harm reduction practices if using this substance. PW

Cannabinoid hyperemesis syndrome (CHS) is recurrent nausea, vomiting, and stomach cramp that sometimes occurs due to prolonged, high-dose cannabis use.[38][39] PW

Cannabis arteritis (CA) is a very rare peripheral vascular disease similar to Buerger's disease.[40] PW

Cannabis use during brain development (including during pregnancy and adolescence) has been shown to interfere with a variety of neurobiological systems. Meta-analysis following ~5 weeks of abstinence reveals lasting changes in the central executive and default mode networks, which are involved in attention and working memory. The extent of these changes as risk factors is not entirely clear.[41] PW

Suicidality

A NIH study found that suicide risk is higher with marijuana users than non-users.[42] PW

On the other hand, the largest study as of 2018 in association with cannabis use and the risk of suicide, there was no found evidence between the two. This study shows that it is unlikely a risk factor for suicide, either directly or as a consequence of use.[43] PW

Not only that, but another study studied the association between cannabis and suicidality also has correlation.[44] PW

The main takeaway from these studies and more is that while suicide risk may be higher with people who use cannabis, cannabis is unlikely the cause or an additional significant factor. PW

Psychosis risk

The prolonged usage of THC and other cannabinoids may increase one's disposition to mental illness and psychosis, particularly in vulnerable individuals with risk factors for psychotic illnesses (like a past or family history of schizophrenia).[45–48] PW

Individuals with a personal or family history of mental illness, particularly psychotic disorders like schizophrenia, should not use cannabis without the advice of a qualified mental health practitioner. PW

Trauma

Cannabis use and trauma are linked, with trauma playing a role in encouraging both the use and potential misuse of cannabis. Conversely, cannabis use has been associated with the intensity of trauma and PTSD symptoms. While evidence of efficacious use of cannabis is growing in novelty, it is not currently recommended.[49–53] PW

Lethal dosage

No fatal overdoses associated with cannabis use have been reported as of 2010. A review published in the British Journal of Psychiatry in February 2001 said that "no deaths directly due to acute cannabis use have ever been reported."[54][55] PW

THC, the principal psychoactive constituent of the cannabis plant, has extremely low physiological toxicity and the amount that can enter the body through the consumption of cannabis plants poses no threat of death. In lab animal tests, scientists have had much difficulty administering a dose of THC that is high enough to be lethal. The dose of THC needed to kill 50% of tested rodents is very high, 2.594 mol/kg, about 815.7 grams of THC per kilogram of body weight, and human deaths from overdose are unheard of.[56][57][58] PW

At present, it is estimated that the LD₅₀ of cannabis is around 1:20,000 or 1:40,000. This means that, in order to induce death, a cannabis smoker would have to consume 20,000 to 40,000 times as much cannabis as is contained in one cannabis cigarette. A user would theoretically have to smoke nearly 1,500 pounds of cannabis within about 15 minutes to induce a lethal response. PW

It is worth noting that the rare condition Cannabinoid Hyperemesis Syndrome (CHS) can cause ongoing nausea, vomiting and severe dehydration which can lead to renal failure and in the worst case this can lead to death.[59][60] PW

Dependence and abuse potential

Cannabis is moderately habit-forming. Research has shown the overall dependence potential for cannabis to be less than that for caffeine, tobacco, alcohol, cocaine or heroin, but higher than that for psilocybin, mescaline, or LSD.[61] PW

Dependence on cannabis is more common amongst heavy users. Cannabis use can lead to increased tolerance and withdrawal symptoms upon stopping usage. Prolonged cannabis usage requires the user to consume higher doses of the substance to achieve a common desirable effect, and reinforce the body's metabolic systems for synthesizing and eliminating it more efficiently.[62–66] PW

Tolerance to many of the effects of cannabis develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 1 - 2 weeks for the tolerance to be reduced to half and 2 - 3 weeks to be back at baseline (in the absence of further consumption). THC has been detected in heavy cannabis users after 77 days of drug abstinence.[67] PW

Cannabis exhibits cross-tolerance with all cannabinoids, meaning that all cannabinoids will have a reduced effect for a period of time upon using cannabis. The mechanisms that create this tolerance to THC are thought to involve changes in cannabinoid receptor function. PW

One study found that about 1 in 10 users of cannabis may develop dependence characterized by the occurrence of a withdrawal syndrome after abstinence. This withdrawal syndrome was found to peak 2-3 days after quitting and is mostly complete by 1 week; however, sleep disturbances and vivid dreams may persist for 2-3 weeks.[68] PW

Testing

Detection
Single Use: blood 1-3 days, saliva 12-24 hrs, urine 1-3 days, hair 0 to 90 days. Regular use: blood 1-2 weeks, saliva 15-50 days, urine 15-50 days, hair 0 to 90 days. Oral single use: blood: 2-7 days TS
Awaiting sourceReagent reactions and test kit guidance from a harm reduction testing service.

Effects

SedationAppetite enhancementMuscle relaxationMuscle spasmsNauseaPain reliefVasodilationCreativity EnhancementAnxiety suppressionAnxietyDream suppressionEmotion enhancementMindfulnessParanoiaSleepiness TS

Overview

Cannabis (also known as THC, marijuana, weed, pot, grass, hemp, zaza, kush, and many others) is a preparation of the cannabis plant that produces psychoactive effects when consumed (via smoking, vaporizing, or ingestion). It is the most used illicit substance in the world. The mechanism of action is binding activity at cannabinoid receptors distributed throughout the body.[1–10] PW⚠ PsychonautWiki itself has flagged this text: citation needed.

A common and widely used psychoactive plant, which is beginning to enjoy legal status for medical and even recreational use in some parts of the world. Usually smoked or eaten, primary effects are relaxation and an affinity towards food - a state described as being 'stoned.'[11–31] TS

Cannabis (/ˈkænəbᵻs/), commonly known as marijuana (/ˌmærəˈwɑːnə/), weed, pot, Mary Jane, and ganja, among other names, is a non-chemically uniform psychoactive drug from the Cannabis plant. Native to Central or South Asia, cannabis has been used as a drug for both recreational and entheogenic purposes and in various traditional medicines for centuries. Tetrahydrocannabinol (THC) is the main psychoactive component of cannabis, which is one of the 483 known compounds in the plant, including at least 65 other cannabinoids, such as cannabidiol (CBD). Cannabis can be used by smoking, vaporizing, within food, or as an extract.[32][33] WP

Cannabis has various mental and physical effects, which include euphoria, altered states of mind and sense of time, difficulty concentrating, impaired short-term memory, impaired body movement (balance and fine psychomotor control), relaxation, and an increase in appetite. Onset of effects is felt within minutes when smoked, but may take up to 90 minutes when eaten (as orally consumed drugs must be digested and absorbed). The effects last for two to six hours, depending on the amount used. At high doses, mental effects can include anxiety, delusions (including ideas of reference), hallucinations, panic, paranoia, and cannabis-induced psychotic disorder (CIPD). There is a strong relation between cannabis use and the risk of psychosis, with cannabis use considered a contributory cause of psychosis. Physical effects include increased heart rate, difficulty breathing, nausea, and behavioral problems in children whose mothers used cannabis during pregnancy; short-term side effects may also include dry mouth and red eyes. Long-term adverse effects may include addiction, decreased mental ability in those who started regular use as adolescents, heart disease, chronic coughing, susceptibility to respiratory infections, and cannabinoid hyperemesis syndrome.[34][35][36] WP

Cannabis is mostly used recreationally or as a medicinal drug, although it may also be used for spiritual purposes. Evidence supports only a few approved uses of cannabinoids and most medical claims, such as efficacy for insomnia or acute pain, lack sufficient evidence. In 2013, between 128 and 232 million people used cannabis (2.7% to 4.9% of the global population between the ages of 15 and 65). It is the most commonly used largely-illegal drug in the world, with the highest use among adults in Zambia, the United States, Canada, and Nigeria. Since the 1970s, the potency of illicit cannabis has increased, with THC levels rising and CBD levels dropping.[37] WP

Cannabis plants have been grown since at least the 3rd millennium BCE and there is evidence of it being smoked for its psychoactive effects around 500 BCE in the Pamir Mountains, Central Asia. Since the 14th century, cannabis has been subject to legal restrictions. The possession, use, and cultivation of cannabis has been illegal in most countries since the 20th century. Uruguay became the first country to legalize recreational use of cannabis in 2013. Other countries to do so are Canada, Georgia, Germany, Luxembourg, Malta, South Africa, and Thailand. In the U.S., the recreational use of cannabis is legalized in 24 states, 3 territories, and the District of Columbia, though the drug remains federally illegal. In Australia, it is legalized only in the Australian Capital Territory. WP

History

Ancient history

Cannabis is indigenous to Central or South Asia and its uses for fabric and rope dates back to the Neolithic age in China and Japan. It is unclear when cannabis first became known for its psychoactive properties. The oldest archeological evidence for the burning of cannabis was found in Romanian kurgans dated 3,500 BC, and scholars suggest that the drug was first used in ritual ceremonies by Proto-Indo-European tribes living in the Pontic-Caspian steppe during the Chalcolithic period, a custom they eventually spread throughout Western Eurasia during the Indo-European migrations. Some research suggests that the ancient Indo-Iranian drug soma, mentioned in the Vedas, sometimes contained cannabis. This is based on the discovery of a basin containing cannabis in a shrine of the second millennium BC in Turkmenistan.[69–74] WP

Cannabis was known to the ancient Assyrians, who discovered its psychoactive properties through the Iranians. Using it in some religious ceremonies, they called it qunubu (meaning "way to produce smoke"), a probable origin of the modern word cannabis. The Iranians also introduced cannabis to the Scythians, Thracians and Dacians, whose shamans (the kapnobatai – "those who walk on smoke/clouds") burned cannabis infructescence to induce trance. The plant was used in China before 2800 BC, and found therapeutic use in India by 1000 BC, where it was used in food and drink, including bhang.[75–79] WP

Cannabis has an ancient history of ritual use and has been used by religions around the world. It has been used as a drug for both recreational and entheogenic purposes and in various traditional medicines for centuries. The earliest evidence of cannabis smoking has been found in the 2,500-year-old tombs of Jirzankal Cemetery in the Pamir Mountains in Western China, where cannabis residue were found in burners with charred pebbles possibly used during funeral rituals. Hemp seeds discovered by archaeologists at Pazyryk suggest early ceremonial practices like eating by the Scythians occurred during the 5th to 2nd century BC, confirming previous historical reports by Herodotus. It was used by Muslims in various Sufi orders as early as the Mamluk period, for example by the Qalandars. Smoking pipes uncovered in Ethiopia and carbon-dated to around c. AD 1320 were found to have traces of cannabis.[80–87] WP

Modern history

Cannabis was introduced to the New World by the Spaniards in 1530–1545. Following an 1836–1840 travel in North Africa and the Middle East, French physician Jacques-Joseph Moreau wrote on the psychological effects of cannabis use; he founded the Paris' Club des Hashischins in 1844. In 1842, Irish physician William Brooke O'Shaughnessy, who had studied the drug while working as a medical officer in Bengal with the East India Company, brought a quantity of cannabis with him on his return to Britain, provoking renewed interest in the West. Examples of classic literature of the period featuring cannabis include Les paradis artificiels (1860) by Charles Baudelaire and The Hasheesh Eater (1857) by Fitz Hugh Ludlow.[88–92] WP

Cannabis was criminalized in some countries beginning in the 14th century and was illegal in most countries by the middle of the 20th century. The colonial government of Mauritius banned cannabis in 1840 over concerns on its effect on Indian indentured workers; the same occurred in Singapore in 1870. In the United States, the first restrictions on sale of cannabis came in 1906 (in the District of Columbia). Canada criminalized cannabis in The Opium and Narcotic Drug Act, 1923, before any reports of the use of the drug in Canada, but eventually legalized its consumption for recreational and medicinal purposes in 2018.[93–97] WP

In 1925, a compromise was made at an international conference in Geneva about the Second International Opium Convention that banned exportation of "Indian hemp" to countries that had prohibited its use, and requiring importing countries to issue certificates approving the importation and stating that the shipment was required "exclusively for medical or scientific purposes". It also required parties to "exercise an effective control of such a nature as to prevent the illicit international traffic in Indian hemp and especially in the resin". In the United States in 1937, the Marihuana Tax Act was passed, and prohibited the production of hemp in addition to cannabis.[98][99][100] WP

In 1972, the Dutch government divided drugs into more- and less-dangerous categories, with cannabis being in the lesser category. Accordingly, possession of 30 g or less was made a misdemeanor. Cannabis has been available for recreational use in coffee shops since 1976. Cannabis products are only sold openly in certain local "coffeeshops" and possession of up to 5 g for personal use is decriminalized, however: the police may still confiscate it, which often happens in car checks near the border. Other types of sales and transportation are not permitted, although the general approach toward cannabis was lenient even before official decriminalization.[101–105] WP⚠ The source also gives this in other units.

In Uruguay, President Jose Mujica signed legislation to legalize recreational cannabis in December 2013, making Uruguay the first country in the modern era to legalize cannabis. In August 2014, Uruguay legalized growing up to six plants at home, as well as the formation of growing clubs (Cannabis social club), and a state-controlled marijuana dispensary regime. WP

As of 17 October 2018, when recreational use of cannabis was legalized in Canada, dietary supplements for human use and veterinary health products containing not more than 10 parts per million of THC extract were approved for marketing; Nabiximols (as Sativex) is used as a prescription drug in Canada.[97] WP

The United Nations' World Drug Report stated that cannabis "was the world's most widely produced, trafficked, and consumed drug in the world in 2010", and estimated between 128 million and 238 million users globally in 2015.[106][107] WP

Pharmacology

Mechanism of action

THC is a weak partial agonist at CB₁ receptors, while CBD is a CB₁ receptor antagonist. The CB₁ receptor is found primarily in the brain as well as in some peripheral tissues, and the CB₂ receptor is found primarily in peripheral tissues, but is also expressed in neuroglial cells. THC appears to alter mood and cognition through its agonist actions on the CB₁ receptors, which inhibit a secondary messenger system (adenylate cyclase) in a dose-dependent manner.[158][159][160] WP

Via CB₁ receptor activation, THC indirectly increases dopamine release and produces psychotropic effects. CBD also acts as an allosteric modulator of the μ- and δ-opioid receptors. THC also potentiates the effects of the glycine receptors. It is unknown if or how these actions contribute to the effects of cannabis.[161–164] WP

Pharmacokinetics

The high lipid-solubility of cannabinoids results in their persisting in the body for long periods of time. Even after a single administration of THC, detectable levels of THC can be found in the body for weeks or longer (depending on the amount administered and the sensitivity of the assessment method). Investigators have suggested that this is an important factor in marijuana's effects, perhaps because cannabinoids may accumulate in the body, particularly in the lipid membranes of neurons.[165][166] WP

Detection in body fluids

THC and its major (inactive) metabolite, THC-COOH, can be measured in blood, urine, hair, oral fluid or sweat using chromatographic techniques as part of a drug use testing program or a forensic investigation of a traffic or other criminal offense. The concentrations obtained from such analyses can often be helpful in distinguishing active use from passive exposure, elapsed time since use, and extent or duration of use. These tests cannot, however, distinguish authorized cannabis smoking for medical purposes from unauthorized recreational smoking. Commercial cannabinoid immunoassays, often employed as the initial screening method when testing physiological specimens for marijuana presence, have different degrees of cross-reactivity with THC and its metabolites. Urine contains predominantly THC-COOH, while hair, oral fluid and sweat contain primarily THC. Blood may contain both substances, with the relative amounts dependent on the recency and extent of usage.[167][168][169] WP

The Duquenois–Levine test is commonly used as a screening test in the field, but it cannot definitively confirm the presence of cannabis, as a large range of substances have been shown to give false positives. Researchers at John Jay College of Criminal Justice reported that dietary zinc supplements can mask the presence of THC and other drugs in urine. However, a 2013 study conducted by researchers at the University of Utah School of Medicine refute the possibility of self-administered zinc producing false-negative urine drug tests.[170][171][172] WP

Chemistry

Awaiting sourceFormula, structure and identifiers from PubChem.

User reports

Erowid erowid.org

Listings

Erowid Experience Vault listing TS

Link as published on TripSit's factsheet.

Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Bluelight bluelight.org

Listings
Awaiting sourceTrip report threads and this substance's discussion forum.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Reddit reddit.com

Listings
Awaiting sourceTrip report posts and the relevant subreddits.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Pop culture

No references added yet.

Add a reference

Registered users can add songs, films, books, shows, games and art about this substance. Link a source that names the substance, such as the work's Wikipedia article, a review or an interview, not only the work itself. Entries are voted on and moderated like every other value on this page.

Opens when accounts launch.

References

  1. Wikipedia Definition of THC
  2. Wikipedia Definition of Marijuana
  3. Other Definition of Weed
  4. Other Definition of POT
  5. Other Definition of Grass
  6. Other Definition of HEMP
  7. Other Definition of Zaza
  8. Other Definition of Kush
  9. Harm reduction site Erowid Cannabis Vault : Legal Status
  10. Harm reduction site WDR-2010
  11. Journal / agency Cannabis use and risk of lung cancer: a case-control study
  12. Journal / agency Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb
  13. Journal / agency Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study
  14. Journal / agency Effects of cannabis on the adolescent brain
  15. Journal / agency Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users
  16. Journal / agency A controlled family study of cannabis users with and without psychosis
  17. Journal / agency How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to
  18. Journal / agency The impact of marijuana use on glucose, insulin, and insulin resistance among US adults
  19. Journal / agency Marijuana and lung diseases
  20. Journal / agency Neuroprotective antioxidants from marijuana
  21. Journal / agency Decreased depression in marijuana users
  22. Journal / agency Self-reported anal sex practice and sexual risk-taking after marijuana use among a sample of Georgia inmates
  23. Journal / agency Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns
  24. Journal / agency Association of marijuana use and the incidence of testicular germ cell tumors
  25. Journal / agency The effects of combinations of intranasal cocaine, smoked marijuana, and task performance on heart rate and blood pressure
  26. Journal / agency Ischemic stroke after use of the synthetic marijuana "spice"
  27. Journal / agency Marijuana's effects on human cognitive functions, psychomotor functions, and personality
  28. Journal / agency Effects of marijuana on human reaction time and motor control
  29. Journal / agency Effects of marijuana on testosterone in male subjects
  30. Journal / agency Detection times of marijuana metabolites in urine by immunoassay and GC-MS
  31. Other Medical/therapeutic value of cannabis literature review
  32. Other cannabis noun – Definition, pictures, pronunciation and usage notes | Oxford Advanced Learner's Dictionary at OxfordLearnersDictionaries.com
  33. Other marijuana noun – Definition, pictures, pronunciation and usage notes | Oxford Advanced Learner's Dictionary at OxfordLearnersDictionaries.com
  34. Journal / agency Hall, Wayne; Yimer, Tesfa M.; Thorne, Rachel Lees; Hoch, Eva; Burke, Chloe; Gridley, Ad; Hurd, Yasmin L.; Wilson, Jack; Leung, Janni; Freeman, Tom P. Relationships between cannabis use and mental disorders: assessing the coherence of evidence from studies with different methodologies. The Lancet Psychiatry. 2026-07-01. doi:10.1016/S2215-0366(26)00086-6 · PMID 42309106
  35. Journal / agency Shrivastava, Amresh; Johnston, Megan; Tsuang, Ming. Cannabis use and cognitive dysfunction. Indian Journal of Psychiatry. 2011. doi:10.4103/0019-5545.86796 · PMID 22135433 · PMC3221171
  36. Other Gregory, Andrew. Cannabis use could double risk of heart deaths, study suggests. 17 June 2025
  37. Journal / agency Hsu, Michael; Shah, Arya; Jordan, Ayana; Gold, Mark S.; Hill, Kevin P. Therapeutic Use of Cannabis and Cannabinoids. JAMA. 2026-01-27. doi:10.1001/jama.2025.19433 · PMID 41296368
  38. Journal / agency Sorensen, Cecilia J.; DeSanto, Kristen; Borgelt, Laura; Phillips, Kristina T.; Monte, Andrew A. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review. Journal of Medical Toxicology. 20 December 2016. doi:10.1007/s13181-016-0595-z · PMID 28000146 · PMC5330965
  39. Journal / agency DeVuono, Marieka; Parker, Linda. Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms. Cannabis and Cannabinoid Research. 2020. doi:10.1089/can.2019.0059
  40. Journal / agency El Omri, N; Eljaoudi, R; Mekouar, F; Jira, M; Sekkach, Y; Amezyane, T; Ghafir, D. Cannabis arteritis. The Pan African medical journal. 2017. doi:10.11604/pamj.2017.26.53.11694 · PMID 28451030
  41. Other Hurd, Yasmin L., et al. “Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects.” Journal of Neuroscience, Society for Neuroscience, 16 Oct. 2019
  42. Journal / agency https://www.nih.gov/news-events/news-releases/canSuicidality
  43. Journal / agency Price, C., Hemmingsson, T., Lewis, G., Zammit, S., Allebeck, P. Cannabis and suicide: longitudinal study. The British Journal of Psychiatry. December 2009. doi:10.1192/bjp.bp.109.065227
  44. Journal / agency Borges, G., Bagge, C. L., Orozco, R. A literature review and meta-analyses of cannabis use and suicidality. Journal of Affective Disorders. 1 May 2016. doi:10.1016/j.jad.2016.02.007
  45. Journal / agency Arseneault, L., Cannon, M., Witton, J., Murray, R. M. Causal association between cannabis and psychosis: examination of the evidence. The British Journal of Psychiatry. February 2004. doi:10.1192/bjp.184.2.110
  46. Journal / agency Every-Palmer, S. Synthetic cannabinoid JWH-018 and psychosis: An explorative study. Drug and Alcohol Dependence. September 2011. doi:10.1016/j.drugalcdep.2011.01.012
  47. Journal / agency Schneir, A. B., Cullen, J., Ly, B. T. “Spice” Girls: Synthetic Cannabinoid Intoxication. The Journal of Emergency Medicine. 1 March 2011. doi:10.1016/j.jemermed.2010.10.014
  48. Journal / agency Vearrier, D., Osterhoudt, K. C. A Teenager With Agitation: Higher Than She Should Have Climbed. Pediatric Emergency Care. June 2010. doi:10.1097/PEC.0b013e3181e4f416
  49. Journal / agency Hyman SM, Sinha R. Stress-related factors in cannabis use and misuse: implications for prevention and treatment. Journal of Substance Abuse Treatment. June 2009. doi:10.1016/j.jsat.2008.08.005 · PMID 19004601 · PMC2696937
  50. Journal / agency Bonn-Miller MO, Vujanovic AA, Feldner MT, Bernstein A, Zvolensky MJ. Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users. Journal of Traumatic Stress. August 2007. doi:10.1002/jts.20243 · PMID 17721963
  51. Journal / agency Kevorkian S, Bonn-Miller MO, Belendiuk K, Carney DM, Roberson-Nay R, Berenz EC. Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample. Psychology of Addictive Behaviors. September 2015. doi:10.1037/adb0000110 · PMID 26415060 · PMC4699174
  52. Journal / agency Black N, Stockings E, Campbell G, Tran LT, Zagic D, Hall WD, Farrell M, Degenhardt L. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. The Lancet. Psychiatry. December 2019. doi:10.1016/s2215-0366(19)30401-8 · PMID 31672337 · PMC6949116
  53. Journal / agency Dagan Y, Yager J. Cannabis and Complex Posttraumatic Stress Disorder: A Narrative Review With Considerations of Benefits and Harms. The Journal of Nervous and Mental Disease. August 2020. doi:10.1097/nmd.0000000000001172 · PMID 32433200
  54. Journal / agency Calabria, B., Degenhardt, L., Hall, W., Lynskey, M. Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use: Adverse effects of cannabis use. Drug and Alcohol Review. 19 January 2010. doi:10.1111/j.1465-3362.2009.00149.x
  55. Journal / agency Ashton, C. H. Pharmacology and effects of cannabis: A brief review. The British Journal of Psychiatry. February 2001. doi:10.1192/bjp.178.2.101
  56. Journal / agency Hall, W., Solowij, N. Adverse effects of cannabis. The Lancet. 14 November 1998. doi:10.1016/S0140-6736(98)05021-1
  57. Harm reduction site https://www.drugbank.ca/drugs/DB00470
  58. Journal / agency Kochanowski, M., Kała, M. Tetrahydrocannabinols in clinical and forensic toxicology. Przeglad Lekarski. 2005
  59. Journal / agency Galli, J. A., Sawaya, R. A., Friedenberg, F. K. Cannabinoid Hyperemesis Syndrome. Current drug abuse reviews. December 2011
  60. Journal / agency Nourbakhsh, M., Miller, A., Gofton, J., Jones, G., Adeagbo, B. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases. Journal of Forensic Sciences. January 2019. doi:10.1111/1556-4029.13819
  61. Journal / agency Lopez-Quintero, C., Cobos, J. P. de los, Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., Blanco, C. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug and alcohol dependence. 1 May 2011. doi:10.1016/j.drugalcdep.2010.11.004
  62. Journal / agency Borgelt, L. M., Franson, K. L., Nussbaum, A. M., Wang, G. S. The Pharmacologic and Clinical Effects of Medical Cannabis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. February 2013. doi:10.1002/phar.1187
  63. Journal / agency Sewell, R. A., Poling, J., Sofuoglu, M. The Effect of Cannabis Compared with Alcohol on Driving. American Journal on Addictions. January 2009. doi:10.1080/10550490902786934
  64. Journal / agency Gordon, A. J., Conley, J. W., Gordon, J. M. Medical Consequences of Marijuana Use: A Review of Current Literature. Current Psychiatry Reports. 14 November 2013. doi:10.1007/s11920-013-0419-7
  65. Journal / agency Lichtman, A. H., Martin, B. R. Cannabinoid tolerance and dependence. Handbook of Experimental Pharmacology. 2005. doi:10.1007/3-540-26573-2_24
  66. Journal / agency Watson, S. J. Marijuana and Medicine: Assessing the Science Base: A Summary of the 1999 Institute of Medicine Report. Archives of General Psychiatry. 1 June 2000. doi:10.1001/archpsyc.57.6.547
  67. Journal / agency Ellis, G. M., Mann, M. A., Judson, B. A., Schramm, N. T., Tashchian, A. Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clinical Pharmacology and Therapeutics. November 1985. doi:10.1038/clpt.1985.226
  68. Journal / agency Winstock, A. R., Ford, C., Witton, J. Assessment and management of cannabis use disorders in primary care. BMJ. 1 April 2010. doi:10.1136/bmj.c1571
  69. Other ElSohly, Mahmoud A. Marijuana and the Cannabinoids. 2007
  70. Other Stafford, Peter G.; Bigwood, Jeremy. Psychedelics Encyclopedia. 1992
  71. Other Barber EJ. Prehistoric Textiles: The Development of Cloth in the Neolithic and Bronze Ages with Special Reference to the Aegean. 1992
  72. Other Anthony, David W. The Horse, the Wheel, and Language: How Bronze-Age Riders from the Eurasian Steppes Shaped the Modern World. 2007
  73. Other Ellens, J. Harold. Seeking the Sacred with Psychoactive Substances: Chemical Paths to Spirituality and to God. 2014
  74. Other Rudgley, Richard. The Encyclopedia of Psychoactive Substances. 1998
  75. Other Franck, Mel. Marijuana Grower's Guide. 1997
  76. Other Rubin, Vera D. Cannabis and Culture. 1976
  77. Other Cunliffe, Barry W. The Oxford Illustrated History of Prehistoric Europe. 2001
  78. Other Schultes, Richard Evans. Hallucinogenic Plants. 1976
  79. Other Staelens, Stefanie. The Bhang Lassi Is How Hindus Drink Themselves High for Shiva. 10 March 2015
  80. Other Vij. Textbook Of Forensic Medicine And Toxicology: Principles And Practice. 2012
  81. Other ShorterOxfordEnglishDictionary
  82. Other Spanish Word Histories and Mysteries: English Words That Come From Spanish. 2007
  83. Journal / agency Ren M, Tang Z, Wu X, Spengler R, Jiang H, Yang Y, Boivin N. The origins of cannabis smoking: Chemical residue evidence from the first millennium BCE in the Pamirs. Science Advances. June 2019. doi:10.1126/sciadv.aaw1391 · PMID 31206023 · PMC6561734
  84. Other Donahue, Michelle. Earliest evidence for cannabis smoking discovered in ancient tombs. 12 June 2019
  85. Other Walton, Robert P. Marijuana, America's New Drug Problem. 1938
  86. Other Taymiyya, Ibn. Le haschich et l'extase. 2001
  87. Other Rubin, Vera. Cannabis and Culture. 1975
  88. Other Booth, Martin. Cannabis: A History. 2004
  89. Other David E. Newton. Marijuana: A Reference Handbook, 2nd Edition. 2017
  90. Other Eileen Konieczny, Lauren Wilson. Healing with CBD. 2018
  91. Other Pilkington, Mark. Clouds of smoke. 2005-07-27
  92. Other Iversen, Leslie L. The Science of Marijuana. 2007
  93. Other A Collection of the Laws of Mauritius and Its Dependencies. 1867
  94. Other Bunyapraphatsōn, Nanthawan. Medicinal and poisonous plants. 1999
  95. Other Statement of Dr. William C. Woodward
  96. Other https://archive.org/stream/actsofparl1923v01cana#page/134/mode/2up. 1923
  97. Other Health products containing cannabis or for use with cannabis: Guidance for the Cannabis Act, the Food and Drugs Act, and related regulations. 11 July 2018
  98. Other Willoughby WW. Opium as an international problem. 1925
  99. Other Google books GJm-XDLJe1QC Opium as an international problem: the Geneva conferences – Westel Woodbury Willoughby
  100. Other USStatute 75 238 50 551 1937 8 2
  101. Other Booth, Martin. Cannabis: A History. 2004
  102. Other Michael Tonry. Crime and Justice. 2015
  103. Harm reduction site Use drop-down menu on site to view Netherlands entry.)
  104. Other Drugs Policy in the Netherlands
  105. Other Amsterdam Will Ban Tourists from Pot Coffee Shops. 27 May 2011
  106. Other Dockterman, Eliana. Marijuana Now the Most Popular Drug in the World. 29 June 2012
  107. Other World Drug Report 2017
  108. Journal / agency Habibi, Roojin; Hoffman, Steven J. Legalizing Cannabis Violates the UN Drug Control Treaties, But Progressive Countries Like Canada Have Options. Ottawa Law Review. March 2018
  109. Other Bewley-Taylor, David; Jelsma, Martin; Rolles, Steve; Walsh, John. Cannabis regulation and the UN drug treaties. June 2016
  110. Other Angell, T. World Health Organization Recommends Reclassifying Marijuana Under International Treaties. 2019
  111. Other Levinson, David. Encyclopedia of Crime and Punishment. 2002
  112. Other Many Dutch coffee shops close as liberal policies change, Exaptica. 27 November 2007
  113. Other 43 Amsterdam coffee shops to close door", Radio Netherlands, Friday 21 November 2008. link 2
  114. Other O'Sullivan, Feargus. Why the Mayor of Copenhagen Wants to Get Into the Marijuana Business. 3 March 2014
  115. Other Johnston, Ian. As cannabis is widely legalised, China cashes in on an unprecedented boom. 5 January 2014
  116. Other Liljas, Per. Could Thailand, which gave world the bong, legalise cannabis for medicinal use? After failed war on drugs, attitudes have softened. 3 June 2017
  117. Other Marijuana goes legal in Washington state amid mixed messages. 7 December 2012
  118. Other Duke, Alan. 2 states legalize pot, but don't 'break out the Cheetos' yet. 8 November 2012
  119. Other Marijuana clubs ring in new year in Colorado as legalized pot smoking begins. 1 January 2013
  120. Other Mintz, Horward. Medical pot: California Supreme Court allows cities to ban weed dispensaries. 6 May 2013
  121. Other US drug control agency will move to reclassify marijuana in a historic shift, AP sources say. 2024-04-30
  122. Other Biden administration plans to drastically change federal rules on marijuana
  123. Other Trump expands access to cannabis in a major shift in drug policy. 2025-12-18
  124. Other Baker, Vicky. Marijuana laws around the world: what you need to know. 11 December 2013
  125. Other Castaldi, Malena. Uruguay pharmacies start selling cannabis straight to consumers. 19 July 2017
  126. Other Scotti, Monique. Marijuana to be legal in Canada starting October 17, Trudeau confirms. 20 June 2018
  127. Other Sapra, Bani. Canada becomes second nation in the world to legalize marijuana. 20 June 2018
  128. Other Uttarakhand To Become First Indian State To Legalise Cannabis Cultivation. 27 November 2015
  129. Harm reduction site South Asia Regional Profile Report
  130. Other Alchimia Blog, Medical marijuana news, December 2015. link 2
  131. Other Butler, Patrick. Cannabis is legal in Canada – here's what you need to know. 17 October 2018
  132. Other Cannabis Act (S.C. 2018, c. 16)
  133. Other This Application Seems Rigorous. Are All These Hoops Necessary?. 5 July 2018
  134. Other Will Craft Cannabis Growers in Canada Succeed Like Craft Brewers?. October 2018
  135. Other Parliament of the Czech Republic. Explanatory Report to Act No. 112/1998 Coll., which amends the Act No. 140/1961 Coll., the Criminal Code, and the Act No. 200/1990 Coll., on misdemeanors. 1998
  136. Other Castaneda, Jorge G. The summit of muted intentions. 31 March 2012
  137. Other Congreso aprobó, en último debate, uso medicinal de la marihuana. 25 May 2016
  138. Other Dosis máximas de droga para consumo ya están vigentes
  139. Other Ecuador: Aprueban tenencia de drogas para consumo" at El Nuevo Herald. link 2
  140. Other Ecuador could regulate the drug industry
  141. Harm reduction site Drug policy profiles – Portugal. 1 June 2011
  142. Other Lindeque, Mia. Dagga users celebrate following ConCourt ruling on private use
  143. Other Williams, Sean. Mexico Aims to Legalize Recreational Marijuana Before October. 28 April 2019
  144. Other Vélez, Manuel. Ley de Narcomenudeo. 17 October 2009
  145. Other Mexico marijuana: Top court decriminalises recreational use of cannabis. 2021-06-28
  146. Other Germany becomes largest EU country to legalize cannabis for recreational use. 2024-04-01
  147. Other Ross, Selena. All eyes on Canada as first G7 nation prepares to make marijuana legal. 6 June 2018
  148. Other Marijuana Overview
  149. Other Smith, Tasha. "New Amsterdam" No More? Spain's Cannabis Clubs Fight to Stay Open. 5 June 2018
  150. Other Haines, Gavin. Everything you need to know about marijuana smoking in the Netherlands. 21 February 2017
  151. Other The Legal Situation of Cannabis in the Netherlands. 20 May 2020
  152. Other Bubola, Emma. Malta Becomes First E.U. Country to Legalize Marijuana. 15 December 2021
  153. Other Massa, Silja. Kevytkannabis saapui Viroon – Suomalaisturistin ei kannata ostaa tuliaisiksi Virossa laillisia tuotteita. 29 June 2019
  154. Other Lebanon legalizes cannabis farming for medicinal use. 21 April 2020
  155. Other Is Weed Legal in Japan? And Other Vacation Info for Cannabis Users. 6 February 2020
  156. Other Here are the absolute worst places on earth to be caught with weed
  157. Other Bong arm of the law: South Korea says it will arrest citizens who smoke weed in Canada. 23 October 2018
  158. Journal / agency Bow, Eric. The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation. Perspectives in Medicinal Chemistry. 2016. doi:10.4137/PMC.S32171 · PMID 27398024 · PMC4927043
  159. Journal / agency Thomas, A. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol. 2007. doi:10.1038/sj.bjp.0707133 · PMID 17245363 · PMC2189767
  160. Journal / agency Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science. April 2002. doi:10.1126/science.1063545 · PMID 11976437
  161. Journal / agency Oleson EB, Cheer JF. A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harbor Perspectives in Medicine. August 2012. doi:10.1101/cshperspect.a012229 · PMID 22908200 · PMC3405830
  162. Journal / agency Kathmann M, Flau K, Redmer A, Tränkle C, Schlicker E. Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. February 2006. doi:10.1007/s00210-006-0033-x · PMID 16489449
  163. Journal / agency Hejazi N, Zhou C, Oz M, Sun H, Ye JH, Zhang L. Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. Molecular Pharmacology. March 2006. doi:10.1124/mol.105.019174 · PMID 16332990
  164. Journal / agency Xiong W, Cheng K, Cui T, Godlewski G, Rice KC, Xu Y, Zhang L. Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia. Nature Chemical Biology. May 2011. doi:10.1038/nchembio.552 · PMID 21460829 · PMC3388539
  165. Other Hall, Wayne; Pacula, Rosalie Liccardo. Cannabis Use and Dependence: Public Health and Public Policy. 2003
  166. Journal / agency Hollister, Leo E. Health aspects of cannabis. Pharma Review. March 1986. doi:10.1016/S0031-6997(25)06862-0 · PMID 3520605
  167. Other Barceloux, Donald G. Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants. 2012
  168. Other Baselt, Randall Clint. Disposition of Toxic Drugs and Chemicals in Man. 2008
  169. Other Shaw, Leslie M.; Kwong, Tai C. The Clinical Toxicology Laboratory: Contemporary Practice of Poisoning Evaluation. 2001
  170. Other Kelly, John; Addanki, Krishna; Bagasra, Omar. The Non-Specificity of the Duquenois-Levine Field Test for Marijuana. January 2012
  171. Journal / agency Venkatratnam A, Lents NH. Zinc reduces the detection of cocaine, methamphetamine, and THC by ELISA urine testing. Journal of Analytical Toxicology. July 2011. doi:10.1093/anatox/35.6.333 · PMID 21740689
  172. Journal / agency Lin CN, Strathmann FG. Elevated urine zinc concentration reduces the detection of methamphetamine, cocaine, THC and opiates in urine by EMIT. Journal of Analytical Toxicology. 10 July 2013. doi:10.1093/jat/bkt056 · PMID 23843421

Text and values on this page are quoted from PsychonautWiki (CC BY-SA 4.0), Wikipedia (CC BY-SA 4.0), TripSit factsheets. Each value links to the exact revision it came from.